Cancer-associated carbohydrates identified by monoclonal antibodies

Human Pathology

Volumn 21, Issue 10, 1990, Pages 1003-1019

  Sell, Stewart ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cancer; carbohydrates; markers; monoclonal antibodies

Indexed keywords

CARBOHYDRATE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

CANCER CELL; HISTOCHEMISTRY; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; HUMAN; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0025093858     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(90)90250-9     Document Type: Article

References (154)

1. Tumor-associated carbohydrates
2. Aberrant glycosylation in cancer and membranes as focused on glycolipids: Overview and perspectives
3. Blood group antigens as markers for normal differentiation and malignant change in human tissue
4. Carbohydrate antigens in human cancer
5. Human monoclonal antibodies to glycolipids and other carbohydrate antigens: Dissection of the humoral immune response in cancer patients
6. Polysaccharides and a glycidamin in the tissue of gastric cancer
7. Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines
8. Isoantigens A, B and H in benign and malignant lesions of the cervix
9. Reactivity of blood group substances of neoplastic oral epithelium
10. Early immunologic diagnois and prognosis of carcinoma
11. Blood group antigens and bladder carcinoma: A perspective
12. Prognosis of transitional cell bladder carcinoma with special reference to ABH blood group isoantigen expression and DNA analysis
13. A-like glood group antigen in gastric cells of patients in blood groups O and B
14. Glycolipids of gastric cancer. The presence of blood group A-active glycolipids in cancer tissue from blood group O patients
15. Isoantigenic expression of Forssman glycolipids in human gastric and colonic mucoasa: Its possible identity with “A-like antigen” in human cancer
16. Isolation, characterization and biosynthesis of Forssman antigen in human lung and carcinoma
17. Tumor-associated glycolipid antigens, their metabolism and organization
18. Surface glycolipid and glycoprotein antigens
19. Anti-1: A cold antibody defining the li relationship in human red cells
20. On the specificity of lectins with a broad agglutination spectrum: Studies on the nature of T antigen and the specific receptors for the lectin Arachis hypogaea (ground nut)
21. Blood group MN precursors as human breast carcinoma associated antigens and “naturally” occurring human cytotoxins against them
22. The presence and significance of the Thompsen-Friedenreich antigen in mammary glands. II. Its topochemistry in normal hyperplastic and carcinoma tissue of the breast
23. Cross reacting carcinoma-associated antigens with blood group and precursor specificities
24. Immunotherapy of human leukemia with neurominidase modified cells
25. Neurominidase and tumor immunotherapy
26. Genuine carcinoma autoantigens
27. Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies
28. Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma
29. Novel fucolipids accumulating in human adenocarcinoma
30. Structure of glycolipids isolated from human embryonal carcinoma cells. Presence of mono- and disialosyl glycolipids with blood group I sequences
31. CA-50 as a tumor marker for monitoring colorectal cancer: Antigen rises in patient post operatively precede clinical manifestations of recurrence
32. Monoclonal antibody detection of a circulating tumor-associated antigen in sera of patients with colorectal, gastric and pancreatic carcinoma
33. The elevation of CA19-9 antigen levels in early detection of pancreatic cancer
34. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants
35. 4) of human adenocarcinoma and the monoclonal antibody (FH9) defining this disialosyl structure
36. 6)
37. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialyated lacto-N-fuco-pentanose
38. Monoclonal antibody detection of a circulating tumor associated antigen. II. A longitudinal evaluation of patients with colorectal cancer
39. a for serologic tests of cancer
40. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as mucins
41. Evaluation of CA 19-9 as a serum marker in pancreatic cancer
42. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic cancer
43. CA 19-9 and pancreatic adnocarcinoma
44. Serum CA-50 as a tumor marker in pancreatic cancer A comparison with CA 19-9
45. A carbohydrate epitope associated with human squamous lung cancer
46. a in combination with onco-developmental antigen, SSEA-1, recognized by two monoclonal antibodies to human milk-fat globule membranes
47. 11 and its analogue: The structural requirements for i-specificities
48. Further studies of the specificities of monoclonal anti-i and anti-I antibodies using chemically synthesized linear oligo-saccharides of the poly-N-acetylactosamine series
49. Characterization of a blood group I-active ganglioside
50. Structure and organization of cell surface glycolipids dependency on cell growth and malignant transformation
51. Accumulation of a blood group antigen precursor in oral premalignant lesions
52. x as a new tumor associated antigen
53. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl Type 2 chain polylactosamine
54. Novel fucolipids accumulating in human adenocarcinoma III A hybridoma antibody (FH9) defining a human cancer-associated difucoganglioside
55. x-related antigen expression in human malignant and nonmalignant colonic tissues
56. Gangliosides of human kidney
57. Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl alpha 2- 〉6 galactosyl residue A preliminary note
58. Isolation of a glycolipid containing fucose, galactose, glucose, and glucosamine from human cancerous tissue
59. A spingolipid having a novel type of ceramide and lacto-N-fucopentoase III
60. Novel fucolipids accumulating in human adenocarcinoma II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain
61. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors
62. Monoclonal antibodies PMN6, PMN9 and PMN81 bind differently to glycolipids containing a sugar sequence occurring in Lacto-N-fucopentoase III
63. Localization and alteration of mono- di- and tri- fucosyl 1-〉3 type chain Structures during human embryogenesis and in human cancer
64. A monoclonal antibody against human colonic adenoma recognizes difucosylated Type-2-blood-group chains
65. The monoclonal antibody directed to difucosylated type 2 chain (Fucα1–2GAlβ-4[Fucα1–3]GlcNAc; Y determinant)
66. 6) and a possible three-dimensional epitope structure
67. b, X and Y blood group antigens in human colonic tumors and normal tissue and in tumor-derived cell lines
68. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are oncodevelopmental antigens
69. Cold agglutination and antibodies and antigens
70. 6) in normal and tumor tissues defined by its monoclonal antibody FH6
71. Expression of a carbohydrate differentiation antigen, stage-specific embryonic antigen 1, in human colonic adenocarcinoma
72. Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure
73. Zur serologischen spezifitasdes carcinomewebes
74. Monoclonal antibody against a Burkitt lymphoma-associated antigen
75. Tissue distribution of the PK antigen as determined by a monoclonal antibody
76. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosyl ceramide) in Burkitt lymphoma and lymphoblastoid cell lines
77. Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland
78. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3
79. A glycolipid antigen associated with Burkett lymphoma defined by a monoclonal antibody
80. Expression of Forssman antigen synthesis and degradation in human lung cancer
81. Human carcinoma associated antigens of the blood group MN system and the hosts response to them
82. Heterophile antigens and antibodies in medicine
83. Blood group H antigen with globo-series structure
84. Shared antigenic determinant expressed on various mammalian melanoma cells
85. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominant ganglioside of B16 melanoma
86. GD3 a prominent ganglioside of human melanoma: Detection and characterization by mouse monoclonal antibody
87. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast
88. Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr transformed human B lymphoid cell lines
89. Ganglioside GM2 as a human tumor antigen (OFA-I-1)
90. Identification of a human adenoectodermal tumor antigen (OFA-I-2) as a ganglioside GD2
91. D2 in tumor tissues and sera of neuroblastoma patients
92. Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibody directed against fucosyl-GM1
93. m1
94. Hanganutziu-Diecher antigen and antibody in pathologic sera and tissue
95. Vaccines containing purified GM2 ganglioside elicit GM2 antibody in melanoma patients
96. Melanoma antigens: Immunological and biological characterization and clinical significance
97. D3 ganglioside: A phase I trial in patients with malignant melanoma
98. Oligosaccharide structures of human colonic mucin
99. Purification, composition, molecular weight and subunit structure of amine submaxillary mucin
100. The structure of glycoprotein oligosaccharides
101. Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: Its identification as Tn antigen
102. Preparation and characterization of monoclonal antibodies directed to the tumor-associated 0-linked sialosyl-2-〉6 α N-Acetylgalactosaminyl (Sialosyl-Tn) epitope
103. A monoclonal antibody that recognizes a cluster of disaccharide, Neu Acaα2-〉6 GalNAc, in mucin glycoproteins
104. Monoclonal antibody B72-3 reacts with a core region structure of 0-linked carbohydrates
105. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3
106. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcimona of the lung as defined by a monoclonal antibody
107. Radiolabeled monoclonal antibody B72.3: Localization in metastatic lesions of colorectal cancer patients
108. Complex carbohydrates as differentiation markers in malignant blood cells: Glycolipids in the human leukemias
109. Carbohydrates as antigenic determinants of glycoproteins
110. Alphafetoprotein
111. Molecular mechanisms of control of albumin and alphafetoprotein production: A system to study the early effects of chemical hepatocarcinomagens
112. Serum α-fetoprotein, albumin and γ-G-globulin in the human conceptus
113. Alphafetoprotein in ontogenesis and its association with malignant tumors
114. Developmental changes in carbohydrate moiety of human alpha-fetoprotein
115. Human α-fetoprotein: Isolation, characterization and demonstration of microheterogeneity
116. Developmental microheterogeneity of mouse α-fetoproteins: Purification and partial characterization
117. Yolk sac: Site of developmental microheterogeneity of mouse α-fetoprotein
118. Lectin affinities for alphafetoprotein in liver cirrhosis hepatocellular and metastatic liver tumor
119. Alpha fetoprotein separation of two molecular variants by affinity chromatography with concanavalin A
120. Microheterogeneity of human alphafetoprotein
121. Further resolution of human α-fetoprotein by affinity electrophoresis with erythroagglutinating phytohemagglutinin of Phaseolus vulgaris lectin
122. Alpha-fetoprotein concanavalin A-binding variants in the diagnosis of neural tube defects and other communicating fetal abnormalities
123. Physical characterization and structural studies of the carcinoembroyonic antigen
124. Isolation and structures of the oligosaccharide units of carcinoembryonic antigen
125. Structure studies of the carbohydrate moieties of carcinoembryonic antigens
126. Cancer markers of the 1990s: Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers
127. Multiple tumor markers in monitoring of ovarian carcinoma
128. Blood group related antigens in colonic carcinogenesis
129. y, A, B, and H)
130. Studies on the function of cell surface glycoproteins. I. Use of antisera to surface membranes in the identification of membrane components relevant to cell-substrate adhesion
131. Carbohydrate moieties of glycoproteins, a re-evaluation of their function
132. Differences in lectin reactivities of cellular glycoconjugates between primary human colorectal carcinomas and their metastases
133. Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1- desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/C-mice
134. Lectin binding by liver and lung metastasizing variants of the murine Lewis lung carcinoma
135. Studies of mammary carcinoma metastasis in a mouse model system. II. Lectin binding properties of cells in relation to the incidence and organ distribution of metastases
136. The role of tumor-cell surface carbohydrate in experimental metastasis
137. Altered cell surface organization of gangliosides and sialylglycoproteins of mouse metastatic variant lines selected in vivo for enhanced lung implantation
138. Enzymic basis for the modulation of cell-surface carbohydrates in lectin-resistant melanoma cells
139. Both acidic-type and neutral type asparaginyl-oligosaccharides of host-cell glycoproteins are altered in Rous sarcoma virus-transformed chick-embryo fibroblasts
140. Change in glycosylation of membrane glycoproteins after transfection of NIH 3T3 with human tumor DNA
141. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing {GlcNAc-β(1,6) Man-α(1,6) Man} and poly-N-acetylloctosamine than baby hamster kidney cells
142. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformed by hydrazinolysis
143. β 1–6 branching of ASM-linked oligosaccharides is directly associated with metastasis
144. Characterization of the structure determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins
145. Asn-linked oligosaccharides in lectin-resistant tumor-cell mutants with varying metastatic potential
146. Studies on cell adhesion and recognition The occurrence of α-mannosidase at the fibroblast cell surface and its possible role in cell recognition
147. Endogeneous galactoside binding lection: A new class of functional tumor cell surface molecules related to metastasis